Venclexta (venetoclax)

pCPA File Number: 21375

Negotiation Status:

Active Negotiation

Indication(s):

In combination with obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

Sponsor/Manufacturer:

AbbVie Corporation

CADTH Project Number:

PC0212-000

pCPA Engagement Letter Issued:

2021-02-23

Negotiation Process Concluded:

Not Applicable